Trials / Active Not Recruiting
Active Not RecruitingNCT06245837
Treatment and Biomarker Testing Patterns,Treatment Outcomes in a/m NSCLC With and Without Actionable Genomic Alterations
Multicenter, Non-interventional, Observational Study of Treatment and Biomarker Testing Patterns, Treatment Outcomes in Advanced/Metastatic NSCLC With and Without Actionable Genomic Alterations in Routine Clinical Practice in Russia
- Status
- Active Not Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,500 (estimated)
- Sponsor
- AstraZeneca · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Planned study population consists of approximately 1500 adult patients with a/m NSCLC in Russia, in about 20 oncological centers (in each center it is expected to recruit about 75 patients) in different regions of Russia in order to provide representative study sample
Conditions
Timeline
- Start date
- 2024-03-20
- Primary completion
- 2026-06-30
- Completion
- 2026-06-30
- First posted
- 2024-02-07
- Last updated
- 2026-02-27
Locations
16 sites across 1 country: Russia
Source: ClinicalTrials.gov record NCT06245837. Inclusion in this directory is not an endorsement.